连萸药对及其主要成分抗肿瘤作用研究进展
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:


Research progress on anti-tumor effects of herb pairs of coptis and evodia and its main components
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    黄连-吴茱萸药对最早出现在宋朝时期,两者一苦一辛,一降一升,对消化系统具有良好的药理作用。现代研究表明,该药对对包括胃癌在内的多种肿瘤具有良好的抗肿瘤活性,但其有效物质基础与协同机制尚不明确。本文总结近10年文献,详细阐述了黄连-吴茱萸药对及其主要单体间的抗肿瘤机制和协同作用机制,文献研究发现该药对在治疗肿瘤与2型糖尿病靶点通路上的共通性。本综述为临床应用小檗碱与吴茱萸碱治疗肿瘤与2型糖尿病提供了新的思路,从信号通路角度讨论了小檗碱与吴茱萸碱协同抗肿瘤的作用机制,为临床抗肿瘤治疗奠定了理论基础。

    Abstract:

    The herb pairs of coptis and evodia first appeared in Song dynasty. One is bitter while the other one is pungent,one falls while the other rises,and this compatibility has an obvious pharmacological effects in digestive system. Modern studies show that the herb pairs of coptis and evodia has a certain anti-gastric cancer and other anti-tumor activity,but its efficient material base and cooperation mechanism remains unclear. This article summarizes literature within ten years,with detailed description about the anti-tumor mechanism and the mechanism of synergism of the couple and its main monomers. At the same time,the research finds out the commonality of the drug in the treatment of tumor and type 2 diabetes mellitus target pathway. This review provides a new idea for the clinical application of berberine and evodiamine in the treatment of tumors and type 2 diabetes mellitus,and elucidates the mecha-nism of the interaction of berberine and evodiamine in anti-tumor from the perspective of signal pathway,which lays a theoretical foundation for anti-tumor in the clinical.

    参考文献
    相似文献
    引证文献
引用本文

殷欢莉,冯易,吴敏,张全.连萸药对及其主要成分抗肿瘤作用研究进展[J].重庆医科大学学报,2018,(5):730-

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2019-05-31
  • 出版日期:
文章二维码